Nifedipine

硝苯地平

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameNifedipine
Drug Alias NameNifedipino硝苯啶Nifedipinum硝苯吡啶利心平 +[26] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsIron OverloadHemochromatosisThalassemia +[18] 
Global Approved IndicationsRaynaud DiseaseHypertensionAngina Pectoris
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Richmond S.A.C.I.F.Institut National De La Santé Et De La Recherche Médicale, France U979Nihon Generic +[5] 
Inactive CompaniesUniversity of Texas Southwestern Medical CenterActavis IncDuke University +[10] 
Active IndicationsEssential HypertensionHypertensionAngina, Stable +[5] 
Inactive IndicationsIron OverloadHemochromatosisThalassemia +[13] 

Other Information

ATC CodeC08CA05
Related LinksWikipediaDrugBankKEGG